Signaling through MHC in transgenic mice generates a population of memory phenotype cytolytic cells that lack TCR

Blood

Volumn 101, Issue 11, 2003, Pages 4520-4528

  McFarland, Hugh I ^a   Hansal, Susan A ^a   Morris, Diane I ^a   McVicar, Daniel W ^a   Love, Paul E ^a   Rosenberg, Amy S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HERMES ANTIGEN; T LYMPHOCYTE RECEPTOR; HLA ANTIGEN CLASS 1; HYBRID PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL KILLING; CELL POPULATION; CELL PROLIFERATION; CHIMERA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMORY CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; ANIMAL; CELL CULTURE; CYTOLOGY; CYTOTOXICITY; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IMMUNOPHENOTYPING; T LYMPHOCYTE SUBPOPULATION; THYMUS;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; MICE; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; THYMUS GLAND; TUMOR CELLS, CULTURED;

EID: 0038142354     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-10-3265     Document Type: Article

References (62)

1. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature. 1988;334:395-402.
2. Samelson LE, Patel MD, Weissman AM. Harford JB, Klausner RD, Antigen activation of mouse T cells induces tyrosine phosphorylation of a polypeptide associated with the T cell antigen receptor. Cell. 1986;46:1083-1090.
3. Clevers H, Alarcon B, Wileman T, Terhorst C. The T cell receptor/CD3 complex: a dynamic protein ensemble. Annu Rev Immunol. 1988;6:629-662.
4. Weiss A, Imboden JB. Cell surface molecules and early events involved in human T lymphocyte activation. Adv Immunol. 1987;41:1-38.
5. Frank SJ, Samelson LE, Klausner RD. The structure and signalling functions of the invariant T cell receptor components. Semin Immunol. 1990;2:89-97.
6. Orloff DG, Ra CS, Frank SJ, Klausner RD, Kinet JP. Family of disulphide-linked dimers containing the zeta and eta chains of the T-cell receptor and the gamma chain of Fc receptors. Nature. 1990;347:189-191.
7. Letourneur F, Klausner RD, T-cell and basophil activation through the cytoplasmic tail of T-cellreceptor zeta family proteins. Proc Natl Acad Sci U S A. 1991;88:8905-8909.
8. Romeo C, Seed B. Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides. Cell. 1991;64:1037-1046.
9. Irving BA, Weiss A. The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways. Cell. 1991;64:891-901.
10. Cambier JC. Antigen and Fc receptor signaling: the awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J Immunol. 1995;155:3281-3285.
11. Love PE, Shores EW. ITAM multiplicity and thymocyte selection: how low can you go? Immunity. 2000;12:591-597.
12. Hwu P, Shafer GE, Treisman J, et al. Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain. J Exp Med. 1993;178:361-366.
13. Roberts MR, Qin L, Zhang D, et al. Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors, Blood. 1994;84:2878-2889.
14. Roberts MR, Cooke KS, Tran AC, et al. Antigen-specific cytolysis by neutrophils and NK cells expressing chimeric immune receptors bearing zeta or gamma signaling domains. J Immunol. 1998;161:375-384.
15. Geiger TL, Leitenberg D, Flavell RA. The TCR zeta-chain immunoreceptor tyrosine-based activation motifs are sufficient for the activation and differentiation of primary T lymphocytes. J Immunol. 1999;162:5931-5939.
16. Tran AC, Zhang D, Byrn R, Roberts MR. Chimeric zeta-receptors direct human natural killer (NK) effector function to permit killing of NK-resistant tumor cells and HIV-infected T lymphocytes. J Immunol. 1995;155:1000-1009.
17. Yu X, Carpenter P, Anasetti C. Advances in transplantation tolerance. Lancet. 2001;357:1959-1963.
18. Fink PJ, Shimonkevitz RP, Bevan MJ, Veto cells. Annu Rev Immunol. 1988;6:115-137.
19. Sambhara SR, Miller RG. Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC. Science. 1991;252:1424-1427.
20. Fink PJ, Weissman IL, Bevan MJ. Haplotype-specific suppression of cytotoxic T cell induction by antigen inappropriately presented on T cells. J Exp Med. 1983;157:141-154.
21. Miller RG. An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it. Nature. 1980;287:544-546.
22. Jacobsen IM, Claesson MH. Veto cell suppression mechanisms in the prevention of allograft rejection. APMIS. 1998;106:345-353.
23. Rammensee HG. Veto function in vitro and in vivo. Int Rev Immunol. 1989;4:175-191.
24. Fink PJ, Rammensee HG, Benedetto JD, Staerz UD, Lefrancois L, Bevan MJ. Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes. J Immunol. 1984;133:1769-1774.
25. Weissman AM, Baniyash M, Hou D, Samelson LE, Burgess WH, Klausner RD. Molecular cloning of the zeta chain of the T cell antigen receptor. Science. 1988;239:1018-1021.
26. Greaves DR, Wilson FD, Lang G, Kioussis D. Human CD2 3′-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice. Cell. 1989;56:979-986.
27. Love PE, Shores EW, Lee EJ, et al. Differential effects of zeta and eta transgenes on early alpha/ beta T cell development. J Exp Med. 1994;179:1485-1494.
28. Hansal SA, Mords DI, Sechler JM, Love PE, Rosenberg AS. Induction of antigen-specific hyporesponsiveness by transplantation of hemopoietic cells containing an MHC class I transgene regulated by a lymphocyte-specific promoter. J Immunol. 1998;161:1063-1068.
29. Hahn WC, Menzin E, Saito T, Germain RN, Bierer BE. The complete sequences of plasmids pFNeo and pMH-Neo: convenient expression vectors for high-level expression of eukaryotic genes in hematopoietic cell lines. Gene. 1993;127:267-268.
30. Hogan B, Beddington R, Constantin F, Lacey E. Manipulating the Mouse Embryo: A Laboratory Manual. Woodbury, NY: Cold Spring Harbor Laboratory Press; 1994.
31. Vacchio MS, EW Shores. Flow cytometric analysis of murine T lymphocytes: a practical guide. Methods Mol Biol. 2000;134:153-176.
32. Kruisbeek AM, Shevach E. Proliferative assays for T cell function. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. Current Protocols in Immunology. New York: John Wiley & Sons; 1994:3.12.
33. Wunderlich J, Shearer G. Induction and measurement of cytotoxic T lymphocyte activity. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. Current Protocols in Immunology. New York: John Wiley & Sons; 1994:3.11.
34. Lyons AB, Parish CR. Determination of lymphocyte division by flow cytometry. J Immunol Methods. 1994;171:131-137.
35. Bottomly K, Davis LS, Lipsky PE. Detection of murine IL-2 and IL-4 using CTLL-2 cells. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. Current Protocols in Immunology. New York: John Wiley & Sons; 1994:6.3.
36. Rosenberg AS. Skin allograft rejection. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. Current Protocols in Immunology. New York: John Wiley & Sons; 1994:4.4.
37. Otten GR, Bikoff E, Ribaudo RK, Kozlowski S, Margulies DH, Germain RN. Peptide and beta 2-microglobulin regulation of cell surface MHC class I conformation and expression. J Immunol. 1992;148:3723-3732.
38. Budd RC, Cerottini JC, Horvath C, et al. Distinction of virgin and memory T lymphocytes: stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J Immunol. 1987;138:3120-3129.
39. Walunas TL, Bruce DS, Dustin L, Loh DY, Bluestone JA. Ly-6C is a marker of memory CD8+ T cells. J Immunol. 1995;155:1873-1883.
40. Zhang X, Sun S, Hwang I, Tough DF, Sprent J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15, Immunity. 1998;8:591-599.
41. Azzam HS, Grinberg A, Lui K, Shen H, Shores EW, Love PE. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J Exp Med. 1998;188:2301-2311.
42. Kane KP, Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. J Exp Med. 1994;179:1011-1015.
43. Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature. 2000;405:537-543.
44. Sawicki MW, Dimasi N, Natarajan K, Wang J, Margulies DH, Mariuzza RA. Structural basis of MHC class I recognition by natural killer cell receptors. Immunol Rev. 2001;181:52-65.
45. Kozlowski S, Takeshita T, Boehncke WH, et al. Excess beta 2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules. Nature. 1991;349:74-77.
46. Dietrich J, Hou X, Wegener AM, Geisler C. CD3 gamma contains a phosphoserine-dependent di-leucine motif involved in down-regulation of the T cell receptor. EMBO J. 1994;13:2156-2166.
47. Luton, F, Buferne M, Legendre V, Chauvet E, Boyer C, Schmitt-Verhulst AM. Role of CD3gamma and CD3delta cytoplasmic domains in cytolytic T lymphocyte functions and TCP/CD3 down-modulation. J Immunol. 1997;158:4162-4170.
48. Borroto A, Lama J, Niedergang F, Dautry-Varsat A, Alarcon B, Alcover A. The CD3 epsilon subunit of the TCR contains endocytosis signals. J Immunol. 1999;163:25-31.
49. Arase H, Salto T, Phillips JH, Lanier LL. Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J Immunol. 2001;167:1141-1144.
50. Ortaldo JR, Winkler-Pickett R, Willette-Brown J, et al. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors. J Immunol. 1999;163:5269-5277.
51. Mason LH, Ortaldo JR, Young HA, Kumar V, Bennett M, Anderson SK. Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2). J Exp Med. 1995;182:293-303.
52. Makrigiannis AP, Gosselin P, Mason LH, et al. Cloning and characterization of a novel activating Ly49 closely related to Ly49A. J Immunol. 1999;163:4931-4938.
53. Ortaido JR, Mason AT, Winkler-Pickett R, Raziuddin A, Murphy WJ, Mason LH. Ly-49 receptor expression and functional analysis in multiple mouse strains. J Leukoc Biol. 1999;66:512-520.
54. Fowlkes BJ, Edison L, Mathieson BJ, Chused TM. Early T lymphocytes: differentiation in vivo of adult intrathymic precursor cells. J Exp Med. 1985;162:802-822.
55. Guidos CJ, Weissman IL. Sequential occurrence of positive and negative selection during T lymphocyte maturation. In: Alt FW, Vogel HJ, eds. Molecular Mechanisms of Immunological Recognition. London: Academic Press; 1993:137-147.
56. Murali-Kdshna K, Ahmed R. Cutting edge: naive T cells masquerading as memory cells. J Immunol. 2000;165:1733-1737.
57. Cho BK, Rao VP, Ge Q, Eisen HN, Chen J. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J Exp Med. 2000;192:549-556.
58. Goldrath AW, Bogatzki LY, Bevan MJ. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med. 2000;192:557-564.
59. Sykes M, Harty MW, Karlhofer FM, Pearson DA, Szot G, Yokoyama W. Hematopoietic cells and radioresistant host elements influence natural killer cell differentiation. J Exp Med. 1993;178:223-229.
60. Brennan J, Mager D, Jefferies W, Takei F, Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties, J Exp Med. 1994;180:2287-2295.
61. Rodella L, Zamai L, Rezzani R, et al. Interieukin 2 and interleukin 15 differentially predispose natural killer cells to apoptosis mediated by endothelial and tumour cells. Br J Haematol. 2001;115:442-450.
62. Sabapathy TK, Cheng Q, Hui KM. Characterization of tumor-specific cytotoxic effector cells with a novel CD3-/Thy-1 + phenotype. Cell Immunol. 1995;166:141-153.